50. Dermatomyositis Clinical trials / Disease details
Clinical trials : 194 / Drugs : 244 - (DrugBank : 89) / Drug target genes : 50 - Drug target pathways : 151
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01315938 (ClinicalTrials.gov) | January 2011 | 15/3/2011 | Abatacept Treatment in Polymyositis and Dermatomyositis | Abatacept Treatment in Polymyositis and Dermatomyositis | Polymyositis;Dermatomyositis | Drug: Abatacept Active Treatment;Drug: Abatacept Delayed-Onset Treatment | Karolinska Institutet | Institute of Rheumatology, Prague;King's College Hospital NHS Trust | Completed | 18 Years | 80 Years | All | 20 | Phase 2 | Czechia;Sweden;Czech Republic |